ISMPP Highlights
Publication Alert: Patients as Partners in Medical Publications: The ISMPP Journey of Engagement
ISMPP is proud to announce that an article on its journey of engagement with patients as partners in medical publications was published on September 9, 2025 in Current Medical Research and Opinion (CMRO).
GenAI in Practice: Share Your Voice, Shape the Future
Artificial Intelligence (AI) is rapidly transforming the way we approach medical communications, but how are ISMPP members really using AI today? Where is AI helping the most, what barriers remain, and what do members want to learn next? These are the questions at the heart of our new GenAI in Practice: An ISMPP Member Survey on Awareness and Application, brought to you by the ISMPP AI Task Force.
Diversity and Innovation… at the 21st Annual Meeting!
The spirit of collaboration among the ISMPP community was alive and thriving at the 21st Annual Meeting of ISMPP, May 12-14, 2025, in Washington, DC.
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
The Dark Side of Publishing: Predatory Journals and Congresses Under Scrutiny
Predatory journals and congresses represent a significant and growing threat to the integrity of medical research, publishing, and scientific dissemination. Raising awareness across all scientific and medical communities, not just among those in publishing, is therefore crucial. This article provides practical guidance, particularly on how to identify and avoid predatory journals and congresses.
Accessibility Matters: Easy Steps to Making Healthcare Information Accessible
Healthcare information has never been more readily available than it is now. However, accessibility goes beyond mere access to information; it encompasses ensuring that all individuals—regardless of physical, sensory, or cognitive ability—can access, understand, and benefit from healthcare content. This article discusses the benefits of accessible healthcare content, current accessibility standards, common barriers, and practical tools and strategies to enhance accessibility.
Generative AI: Catalyzing Change in How Pharmaceutical Companies and Agencies Collaborate
Medical communications professionals within pharmaceutical companies and agencies are navigating the rapid acceleration of technological advances, particularly the implications and uptake of generative artificial intelligence (AI), amidst an evolving information ecosystem. This article synthesizes the transformation taking place and shares tips that catalyze collaboration as our industry, and cross-functional relationships, evolve in the age of AI.
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
Poll Results: Level of Detail for Efficacy and Safety Data in a Clinical Study Publication?
You are a medical publication professional in a pharmaceutical company, working on a clinical trial publication for a novel drug that has the potential to revolutionize the treatment of a life-threatening disease. Some of the authors are keen to emphasize the promising efficacy outcomes without, in your opinion, incorporating the same level of detail about certain adverse events. What Would You Do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals